Treating cutaneous squamous cell carcinoma using 5-aminolevulinic acid polylactic-co-glycolic acid nanoparticle-mediated photodynamic therapy in a mouse model
International Journal of Nanomedicine2015Vol. 10, pp. 347–347
Citations Over TimeTop 10% of 2015 papers
Lei Shi, Xiaojie Wang, Qingfeng Tu, Hongwei Wang, Haiyan Zhang, Peiru Wang, Linglin Zhang, Zheng Huang, Xiuli Wang, Feng Zhao, Hansen Luan
Abstract
PLGA NPs provide a promising strategy for delivering ALA in topical PDT of cutaneous SCC.
Related Papers
- → 5‐Aminolevulinic acid‐mediated photodynamic therapy for bladder cancer(2017)141 cited
- → How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications(2021)12 cited
- → Photometrical and dosimetrical measurements for photodynamic diagnosis and therapy with ALA and h-ALA induced PpIX(2003)
- → Mitochondria as the target organelle for protoporphyrin IX (PPIX) accumulation and toxicity in photodynamic diagnosis (PDD) and photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA)(2001)
- → Photometrical and dosimetrical measurements for Photodynamic Diagnosis and Therapy with ALA and h-ALA induced PpIX(2003)